American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 2013.
Bechtold J, Hipwell A, Lewis DA, Loeber R, Pardini D. Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms. Am J Psychiatry. 2016 Aug 1. 173 (8):781-9. [QxMD MEDLINE Link]. [Full Text].
Mathes B, Wood SJ, Proffitt TM, Stuart GW, Buchanan JA, Velakoulis D, et al. Early processing deficits in object working memory in first-episode schizophreniform psychosis and established schizophrenia. Psychol Med. 2005 Jul. 35(7):1053-62. [QxMD MEDLINE Link].
Sautter F, McDermott B, Garver D. The course of DSM-III-R schizophreniform disorder. J Clin Psychol. 1993 May. 49(3):339-44. [QxMD MEDLINE Link].
Clarke M, Whitty P, Browne S, McTigue O, Kamali M, Gervin M, et al. Untreated illness and outcome of psychosis. Br J Psychiatry. 2006 Sep. 189:235-40. [QxMD MEDLINE Link].
Lee SJ, Kim B, Oh D, Kim MK, Kim KH, Bang SY, et al. White matter alterations associated with suicide in patients with schizophrenia or schizophreniform disorder. Psychiatry Res Neuroimaging. 2016 Feb 28. 248:23-9. [QxMD MEDLINE Link].
Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry. 2007 Jan. 68(1):81-6. [QxMD MEDLINE Link].
Fraguas D, de Castro MJ, Medina O, Parellada M, Moreno D, Graell M, et al. Does diagnostic classification of early-onset psychosis change over follow-up?. Child Psychiatry Hum Dev. 2008 Jun. 39(2):137-45. [QxMD MEDLINE Link].
Benazzi F, Mazzoli M, Rossi E. A follow-up and family study of DSM-III-R schizophreniform disorder with good prognostic features. Eur Arch Psychiatry Clin Neurosci. 1992. 242(2-3):119-21. [QxMD MEDLINE Link].
Troisi A, Pasini A, Bersani G, Di Mauro M, Ciani N. Negative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorder. Acta Psychiatr Scand. 1991 May. 83(5):391-4. [QxMD MEDLINE Link].
Ayesa-Arriola R, Rodríguez-Sánchez JM, Suero ES, Reeves LE, Tabarés-Seisdedos R, Crespo-Facorro B. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur Arch Psychiatry Clin Neurosci. 2016 Oct. 266 (7):619-28. [QxMD MEDLINE Link].
Colombo RR, Schaufelberger MS, Santos LC, Duran FL, Menezes PR, Scazufca M, et al. Voxelwise evaluation of white matter volumes in first-episode psychosis. Psychiatry Res. 2012 Jun 30. 202(3):198-205. [QxMD MEDLINE Link].
Stromgren LS. Electroconvulsive Therapy in Aarhus, Denmark, in 1984: Its Application in Nondepressive Disorders. Convuls Ther. 1988. 4(4):306-313.
Compton MT. Barriers to initial outpatient treatment engagement following first hospitalization for a first episode of nonaffective psychosis: a descriptive case series. J Psychiatr Pract. 2005 Jan. 11(1):62-9. [QxMD MEDLINE Link].
Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry. 2009 Feb. 166(2):152-63. [QxMD MEDLINE Link].
Sajatovic M, Mullen JA, Sweitzer DE. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry. 2002 Dec. 63(12):1156-63. [QxMD MEDLINE Link].
Emsley RA. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group. Schizophr Bull. 1999. 25(4):721-9. [QxMD MEDLINE Link].
Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C Jr, Tollefson GD. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry. 1999 Jan. 156(1):79-87. [QxMD MEDLINE Link].